See more : Galaxia SM, Inc. (011420.KS) Income Statement Analysis – Financial Results
Complete financial analysis of Renovacor, Inc. (RCOR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Renovacor, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Brain+ A/S (BRAINP.CO) Income Statement Analysis – Financial Results
- Trillion Energy International Inc. (TCF.CN) Income Statement Analysis – Financial Results
- Canadian National Railway Company (CNR.TO) Income Statement Analysis – Financial Results
- Digital Bros S.p.A. (DIB.MI) Income Statement Analysis – Financial Results
- Javelin Minerals Limited (JAV.AX) Income Statement Analysis – Financial Results
Renovacor, Inc. (RCOR)
About Renovacor, Inc.
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). The company's lead product candidate is REN-001, a recombinant adeno-associated virus 9-based gene therapy designed to deliver a functional BAG3 gene to augment BAG3 protein levels in cardiomyocytes, and slow or halt progression of BAG3 DCM. It is also developing a pipeline of BAG3-associated gene therapies for diseases with high unmet medical need associated with mutations in the BAG3 gene and mechanistically linked to BAG3's expression and function. The company was founded in 2013 and is based in Greenwich, Connecticut.
SHAREHOLDER ALERT: Weiss Law Reminds LFG, ECOM, LOTZ, and RCOR Shareholders About Its Ongoing Investigations
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RCOR, SMBC, TALO
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STOR, RCKT, RCOR, FCRD
Source: https://incomestatements.info
Category: Stock Reports